NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE227774 Query DataSets for GSE227774
Status Public on May 01, 2023
Title Differential gene expression profile analysis of parental, Cas9-p15 control, and MELK knockout cells
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Triple-negative breast cancer (TNBC) has high relapse and metastasis rates and a high proportion of cancer stem-like cells (CSCs), which possess self-renewal and tumor initiation capacity. MELK (maternal embryonic leucine zipper kinase), a protein kinase of the Snf1/AMPK kinase family, is known to promote CSC maintenance and malignant transformation. Our study showed that MELK knockdown using siRNA or MELK inhibition using the MELK inhibitor MELK-In-17 significantly reduced invasiveness, reversed epithelial-to-mesenchymal transition (EMT), and reduced CSC self-renewal and maintenance in TNBC cells. Nude mice injected with CRISPR MELK-knockout MDA-MB-231 cells exhibited suppression of lung metastasis and improved overall survival compared with mice injected with control cells. Furthermore, MELK-In-17 suppressed 4T1 tumor growth in syngeneic BALB/c mice. Our findings indicate that MELK supports metastasis by promoting EMT and the CSC phenotype in TNBC. In our microarray analysis, we identified potential downstream targets of MELK, including STAT5 and NF-kB target genes, as well as genes involved in tumor progression and metastasis (i.e., EMT, angiogenesis, hypoxia, and apical junction). EMT was the most strongly enriched hallmark among genes highly expressed in Cas9-p15 control cells, further confirming that EMT is a major factor contributing to MELK-induced metastasis in TNBC. We also identified a direct physical interaction partner (PRKAB2) of MELK and a set of intermediate proteins (CDC25B, EZH2, FOXM1, JUN, MAP3K5, PRKAB1, PRKAB2, and SMAD2), suggesting that these proteins are key components of MELK-induced signal transduction.
 
Overall design RNA was extracted from parental, Cas9-p15 control, and MELK KO MDA-MB-231 cells. RNA was hybridized onto Affymetrix Human Transcriptome Arrays (version 2.0). Raw gene expression data were read into R using the BioC-package affy, normalized using the Robust MultiArray (RMA) algorithm, and log2-transformed. Probes with normalized expression values exceeding log2(100) in at least 25% of the arrays were filtered for further analysis. In addition, redundancy in probes mapping to the same gene was removed by retaining only the probe with the largest reported variation in gene expression measured by standard deviation. In total, 10,059 unique genes were included for final analysis.
 
Contributor(s) Bartholomeusz C
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Mar 20, 2023
Last update date May 03, 2023
Contact name Chandra Bartholomeusz
E-mail(s) chbartho@mdanderson.org
Phone 713-745-1086
Organization name The University of Texas MD Anderson Cancer Center
Street address 1515 Holcombe Blvd
City HOUSTON
State/province TX
ZIP/Postal code 77030
Country USA
 
Platforms (1)
GPL17586 [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version]
Samples (12)
GSM7107995 MDA-MB-231 parental, biological rep1
GSM7107996 MDA-MB-231 parental, biological rep2
GSM7107997 MDA-MB-231 parental, biological rep3
Relations
BioProject PRJNA946793

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE227774_Master_regulators_of_gene_expression_20221021_ORAPaths.xlsx 20.2 Kb (ftp)(http) XLSX
GSE227774_RAW.tar 285.7 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap